VVOS
Vivos Therapeutics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$14.42M
P/E Ratio
—
EPS
$-1.77
Beta
6.90
52W High
$7.95
52W Low
$1.08
50-Day MA
$1.39
200-Day MA
$2.83
Dividend Yield
—
Profit Margin
-98.80%
Forward P/E
—
PEG Ratio
—
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
Fundamentals
| Revenue (TTM) | $17.32M |
| Gross Profit (TTM) | $9.65M |
| EBITDA | $-15.31M |
| Operating Margin | -69.80% |
| Return on Equity | -335.40% |
| Return on Assets | -49.80% |
| Revenue/Share (TTM) | $1.93 |
| Book Value | $0.31 |
| Price-to-Book | 5.65 |
| Price-to-Sales (TTM) | 0.83 |
| EV/Revenue | 1.369 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 75.70% |
| Shares Outstanding | $11.82M |
| Float | $6.77M |
| % Insiders | 33.08% |
| % Institutions | 9.64% |
Historical Volatility
HV 10-Day
84.62%
HV 20-Day
70.87%
HV 30-Day
65.80%
HV 60-Day
63.99%
HV Rank
25.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.00 target)
2
Buy1
HoldData last updated: 4/14/2026